Your browser doesn't support javascript.
loading
Target-induced clustering activates Trim-Away of pathogens and proteins.
Zeng, Jingwei; Santos, Ana Filipa; Mukadam, Aamir S; Osswald, Mariana; Jacques, David A; Dickson, Claire F; McLaughlin, Stephen H; Johnson, Christopher M; Kiss, Leo; Luptak, Jakub; Renner, Nadine; Vaysburd, Marina; McEwan, William A; Morais-de-Sá, Eurico; Clift, Dean; James, Leo C.
Afiliação
  • Zeng J; Medical Research Council, Laboratory of Molecular Biology, Cambridge, UK.
  • Santos AF; i3S-Instituto de Investigação e Inovação em Saúde and IBMC Instituto de Biologia Molecular e Celular, Universidade do Porto, Porto, Portugal.
  • Mukadam AS; Department of Clinical Neurosciences, UK Dementia Research Institute, University of Cambridge, Cambridge, UK.
  • Osswald M; i3S-Instituto de Investigação e Inovação em Saúde and IBMC Instituto de Biologia Molecular e Celular, Universidade do Porto, Porto, Portugal.
  • Jacques DA; EMBL Australia Node, Single Molecule Science, School of Medical Sciences, University of New South Wales, Sydney, New South Wales, Australia.
  • Dickson CF; EMBL Australia Node, Single Molecule Science, School of Medical Sciences, University of New South Wales, Sydney, New South Wales, Australia.
  • McLaughlin SH; Medical Research Council, Laboratory of Molecular Biology, Cambridge, UK.
  • Johnson CM; Medical Research Council, Laboratory of Molecular Biology, Cambridge, UK.
  • Kiss L; Medical Research Council, Laboratory of Molecular Biology, Cambridge, UK.
  • Luptak J; Medical Research Council, Laboratory of Molecular Biology, Cambridge, UK.
  • Renner N; Medical Research Council, Laboratory of Molecular Biology, Cambridge, UK.
  • Vaysburd M; Medical Research Council, Laboratory of Molecular Biology, Cambridge, UK.
  • McEwan WA; Department of Clinical Neurosciences, UK Dementia Research Institute, University of Cambridge, Cambridge, UK. wm305@cam.ac.uk.
  • Morais-de-Sá E; i3S-Instituto de Investigação e Inovação em Saúde and IBMC Instituto de Biologia Molecular e Celular, Universidade do Porto, Porto, Portugal. eurico.sa@ibmc.up.pt.
  • Clift D; Medical Research Council, Laboratory of Molecular Biology, Cambridge, UK. dclift@mrc-lmb.cam.ac.uk.
  • James LC; Medical Research Council, Laboratory of Molecular Biology, Cambridge, UK. lcj@mrc-lmb.cam.ac.uk.
Nat Struct Mol Biol ; 28(3): 278-289, 2021 03.
Article em En | MEDLINE | ID: mdl-33633400
ABSTRACT
Trim-Away is a recently developed technology that exploits off-the-shelf antibodies and the RING E3 ligase and cytosolic antibody receptor TRIM21 to carry out rapid protein depletion. How TRIM21 is catalytically activated upon target engagement, either during its normal immune function or when repurposed for targeted protein degradation, is unknown. Here we show that a mechanism of target-induced clustering triggers intermolecular dimerization of the RING domain to switch on the ubiquitination activity of TRIM21 and induce virus neutralization or drive Trim-Away. We harness this mechanism for selective degradation of disease-causing huntingtin protein containing long polyglutamine tracts and expand the Trim-Away toolbox with highly active TRIM21-nanobody chimeras that can also be controlled optogenetically. This work provides a mechanism for cellular activation of TRIM RING ligases and has implications for targeted protein degradation technologies.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ribonucleoproteínas / Ubiquitinação / Proteólise Limite: Animals / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ribonucleoproteínas / Ubiquitinação / Proteólise Limite: Animals / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article